Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocatalysis: An essential tool for API synthesis
Naveen Kulkarni, CEO, Quantumzyme, explains how the area of biocatalysis is progressing quickly and the advantages it brings for…
US FDA gives tentative approval to Lupin for Drospirenone tablets
Drospirenone tablets had estimated annual sales of $141 million in the US
Sanofi and AstraZeneca win EU approval for prevention of infant RSV
The long-acting therapy, also known as nirsevimab, was given the European Union (EU) marketing authorisation for the prevention of…
Cipla beats estimates with 11 per cent rise in quarterly profit
The company has been on an acquisition spree in recent months, from buying supplement maker Endura Mass to stake purchases in…
Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables
The drug major also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further…
50 million doses of Covaxin set to expire early 2023
Due to lack of product demand, production stoppage of Covaxin - a two dose jab, was initiated by Bharat Biotech earlier this year,…
Pharma industry reports 79 M&A deals in October 2022
The industry reported 102 Venture Capital (VC) deals worth $1.8 billion in October 2022, compared to the last 12-month average…
India looking at greater market access for pharma products in UK under proposed FTA: Official
The official said that both the countries are trying to secure a deal which is in their national interest
Hester Bosciences announces results for Q2 and H1 FY23
The company has achieved the highest quarterly sales in its history
Decoding compliance management in pharma sector
Rishi Agrawal, Co-founder and CEO, TeamLease Regtech, explains the numerous challenges encountered by the pharma industry, while…